GlobeNewswire
-
AriBio’s Oral AR1001 Meets Primary Efficacy Objective in Prespecified Monotherapy Population in Phase 3 POLARIS-AD Trial
17/11/2026 -
Novartis Cosentyx® becomes first and only FDA-approved anti-IL-17 biologic for people with polymyalgia rheumatica (PMR)
17/11/2026 -
InspireMD Announces Talks Featuring CGuard and CGuard Prime at VEITHsymposium 2026
16/11/2026 -
Kyntra Bio Reports Third Quarter 2026 Financial Results and Provides Business Update
16/11/2026 -
Glass House Brands Reports Third Quarter 2026 Financial Results
16/11/2026 -
ORIC® Pharmaceuticals Reports Third Quarter 2026 Financial Results and Provides Operational and Rinzimetostat Program Updates
16/11/2026 -
20/20 BioLabs Reports Third Quarter 2026 Financial Results and Recent Business Updates
16/11/2026 -
LeonaBio Reports Third Quarter 2026 Financial Results and Provides Business Update
16/11/2026 -
Connect Biopharma Reports Third Quarter 2026 Financial Results and Provides Business Update
16/11/2026 -
Nanox to Report Third Quarter 2026 Financial Results on November 25, 2026
16/11/2026 -
Insight Molecular Diagnostics Announces Proposed Public Offering
16/11/2026 -
Rosemont Pharmaceuticals to acquire Aytu BioPharma to accelerate US expansion
16/11/2026 -
Senseonics and Beta Bionics Launch Eversense® 365 and iLet® Bionic Pancreas Integration
16/11/2026 -
Senseonics and Beta Bionics Launch Eversense® 365 and iLet® Bionic Pancreas Integration
16/11/2026 -
Genelux Corporation Reports Third Quarter Financial Results and Provides Business Updates
16/11/2026 -
AEON Biopharma Reports Third Quarter 2026 Financial Results and Provides Corporate Update
16/11/2026 -
Precision Optics Reports First Quarter Fiscal 2027 Financial Results
16/11/2026 -
Olema Oncology to Participate in Upcoming Investor Conferences
16/11/2026 -
Traws Pharma Reports Third Quarter 2026 Financial Results and Provides Business Highlights
16/11/2026
Pages